The Randomized Registry Trial — The Next Disruptive Technology in Clinical Research?
National Heart Lung and Blood Institute · Office of the Director
Indexed incrossrefpubmed
Abstract
The registry-based randomized trial may make less expensive, more efficient clinical studies possible. But before the new study design can be widely used, questions about the quality of the underlying data sets must be addressed.
Citation impact
587
total citations
- FWCI
- 255.75
- Percentile
- 100%
- References
- 4
Citations per year
Authors
2Topics & keywords
Topics
Keywords
- Medicine
- Randomized controlled trial
- Clinical trial
- Research design
- Clinical research
- Medical physics
- Surgery
- Pathology
No related works found for this paper.